A ventilator is a machine that helps patients to take breaths when he or she cannot do it on their own. It is also known as a mechanical ventilator, breathing machine, and respirator. Ventilators can be set to take a certain number of breaths per minute. This machine does not cure any illness that caused breathing problems, however, it helps to survive until the patient gets better and lungs can work on their own. There are a variety of ventilators available in the market that can be used particularly in ICUs, emergency departments, anesthesia workstations, MRI rooms, operation theatres, aircraft, ambulances and homecare.
According to IQ4I analysis, the Ventilators market is estimated to reach $2,037.0 million by 2027. The factors such as rising incidences of respiratory diseases, rapid growth in the geriatric population requiring long term ventilation, increase in the number of premature birth and the emergence of the COVID-19 pandemic are the factors driving the market growth, technological advancements such as hybrid respiratory solutions, wireless connectivity, high-performance turbine-based ventilators, helmet based ventilators and 3D printing are the opportunities for the growth. Whereas the increase in product recalls, the high cost of the ventilators and complications associated with the use of ventilators in neonates are restraining the market growth. The threat to the ventilators market includes a lack of awareness about the disorder, stringent regulatory requirements for new product approvals and a shortage of skilled professionals.
The ventilator's global market is segmented based on the product, power base, mobility, interphase, end-users and geography. Based on product the market is segmented into ventilator machines and accessories, the ventilator machines segment accounted for the largest revenue of $XX million in 2020 due to an increase in respiratory disorder patient population and increase in the number of premature birth and the emergence of the COVID-19 pandemic are the factors driving the market growth. Ventilator machines are further segmented into ICU ventilators, emergency and transport ventilators and others. ICU ventilators accounted for the largest revenue of $XX million in 2020, due to increased patient population and increased demand for the non-invasive ventilator. ICU ventilators are further segmented into AICU and NICU ventilator, among these, AICU ventilator is accounted for the largest revenue of $XX million in 2020. Accessories are segmented into, ventilator masks, filters and others, among these, ventilator masks accounted for the largest revenue of $XX million in 2020, due to increased efficacy and increased demand for the non-invasive device. Based on the power base, the ventilators market is segmented into pneumatic, electric and combined power base. Among these, the electric segment commanded the largest revenue of $XX million in 2020, Based on mobility, ventilators are segmented into stationary ventilator and transport/portable ventilator, among these, transport/portable ventilator commanded the largest revenue of $XX million in 2020 The ventilator market based on the interphase is segmented into invasive and non-invasive. Among these, non-invasive accounted for the largest revenue $XX million in 2020. Increased prevalence of respiratory disorders and an increase in the use of non-invasive are the factors driving the market.
The ventilator market based on end-user is segmented into hospitals, ambulatory surgical centers, home healthcare and others. Among these, hospitals accounted for the largest revenue of $XX million in 2020 due to an increase in the use of ICU ventilators, increase in hospitalization, ICU beds and increased surgeries. Geographically, North America accounted for the largest revenue of $XX million in 2020, due to increased healthcare expenditure, an increase in funding and R&D investments for the development of ventilators.
Major players in Ventilators global market are Koninklijke Philips N.V. (The Netherlands), GE Healthcare (U.S.), Medtronic, PLC (Ireland), ResMed Inc. (U.S.), Ventec Life Systems (U.S.), Vyaire Medical Inc. (U.S.), Hamilton Medical Corporation (Switzerland), Asahi Kasei Group Company (Zoll Medical Corporation) (Japan), Getinge AB (Sweden), Air Liquide Medical System SA (France), and Shenzhen Mindray Bio-Medical Electrics Co., Ltd. (China).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
ÌýÌý2.6.1 MARKET SIZE ESTIMATION
ÌýÌý2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
ÌýÌý2.6.3 SECONDARY SOURCES
ÌýÌý2.6.4 PRIMARY SOURCES
ÌýÌý2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
ÌýÌý2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
ÌýÌý2.6.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
ÌýÌý3.3.1 DRIVERS AND OPPORTUNITIES
ÌýÌýÌýÌý3.3.1.1 Rising incidences of respiratory diseases
ÌýÌýÌýÌý3.3.1.2 Rapid growth in the geriatric population requiring long term ventilation
ÌýÌýÌýÌý3.3.1.3 Increase in the number of premature birth
ÌýÌýÌýÌý3.3.1.4 Advancements of technology
ÌýÌýÌýÌý3.3.1.5 The emergence of the COVID-19 pandemic is increasing the demand for ventilators
ÌýÌýÌýÌý3.3.1.6 Increase in number of ICU beds, hospitalization and surgeries
ÌýÌý3.3.2 RESTRAINTS AND THREATS
ÌýÌýÌýÌý3.3.2.1 Product recalls and quality issues
ÌýÌýÌýÌý3.3.2.2 The high cost of ventilators
ÌýÌýÌýÌý3.3.2.3 Complications associated with the use of ventilators in neonates
ÌýÌýÌýÌý3.3.2.4 Shortage of skilled professionals
ÌýÌýÌýÌý3.3.2.5 Stringent regulatory policies
ÌýÌýÌýÌý3.3.2.6 Lack of awareness of the disease
3.4 REGULATORY AFFAIRS
ÌýÌý3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
ÌýÌýÌýÌý3.4.1.1 ISO 9001: 2015 Quality Management System
ÌýÌýÌýÌý3.4.1.2 ISO 13485 Medical Devices
ÌýÌý3.4.2 THE U.S.
ÌýÌý3.4.3 CANADA
ÌýÌý3.4.4 EUROPE
ÌýÌý3.4.5 INDIA
ÌýÌý3.4.6 CHINA
ÌýÌý3.4.7 JAPAN
3.5 PORTER’S FIVE FORCE ANALYSIS
ÌýÌý3.5.1 THREAT OF NEW ENTRANTS
ÌýÌý3.5.2 THREAT OF SUBSTITUTES
ÌýÌý3.5.3 COMPETITIVE RIVALRY
ÌýÌý3.5.4 BARGAINING POWER OF SUPPLIERS
ÌýÌý3.5.5 BARGAINING POWER OF BUYERS
3.6 SUPPLY CHAIN ANALYSIS
3.7 MARKET SHARE ANALYSIS
ÌýÌý3.7.1 VENTILATOR GLOBAL MARKET SHARE ANALYSIS
ÌýÌý3.7.2 ICU VENTILATOR GLOBAL MARKET SHARE ANALYSIS
ÌýÌý3.7.3 EMERGENCY VENTILATOR GLOBAL MARKET SHARE ANALYSIS
3.8 CLINICAL TRIALS
3.9 APPROVAL
3.10 VENTILATORS-FUNDING SCENARIO
3.11 VENTILATORS UNITS SOLD AND INSTALLED BASE CALCULATION
4 VENTILATORS GLOBAL MARKET, BY PRODUCT
4.1 INTRODUCTION
ÌýÌý4.1.1 INSTRUMENTS/ VENTILATOR MACHINES
ÌýÌýÌýÌý4.1.1.1 ICU Ventilator
ÌýÌýÌýÌýÌýÌý4.1.1.1.1 AICU Ventilator
ÌýÌýÌýÌýÌýÌý4.1.1.1.2 NICU Ventilator
ÌýÌýÌýÌý4.1.1.2 Emergency and Transport Ventilators
ÌýÌýÌýÌý4.1.1.3 Others
ÌýÌý4.1.2 ACCESSORIES
ÌýÌýÌýÌý4.1.2.1 Ventilator masks
ÌýÌýÌýÌý4.1.2.2 Filters
ÌýÌýÌýÌý4.1.2.3 Others
5 VENTILATORS GLOBAL MARKET, BY POWER BASE
5.1 INTRODUCTION
5.2 PNEUMATIC VENTILATORS
5.3 ELECTRIC VENTILATOR
5.4 COMBINED POWER BASE VENTILATOR
6 VENTILATORS GLOBAL MARKET, BY MOBILITY
6.1 INTRODUCTION
6.2 STATIONARY VENTILATOR
6.3 PORTABLE VENTILATORS
7 VENTILATORS GLOBAL MARKET, BY INTERPHASE
7.1 INTRODUCTION
ÌýÌý7.1.1 NON-INVASIVE VENTILATORS
ÌýÌý7.1.2 INVASIVE VENTILATORS
8 VENTILATORS GLOBAL MARKET, BY END-USERS
8.1 INTRODUCTION
8.2 HOSPITALS
8.3 AMBULATORY SURGICAL CENTERS
8.4 HOME HEALTHCARE
8.5 OTHERS
9 VENTILATORS GLOBAL MARKET BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
ÌýÌý9.2.1 THE U.S.
ÌýÌý9.2.2 REST OF NORTH AMERICA
9.3 EUROPE
ÌýÌý9.3.1 GERMANY
ÌýÌý9.3.2 U.K.
ÌýÌý9.3.3 ITALY
ÌýÌý9.3.4 REST OF E.U.
9.4 APAC
ÌýÌý9.4.1 JAPAN
ÌýÌý9.4.2 CHINA
ÌýÌý9.4.3 INDIA
ÌýÌý9.4.4 REST OF APAC
9.5 REST OF THE WORLD
ÌýÌý9.5.1 BRAZIL
ÌýÌý9.5.2 TURKEY
ÌýÌý9.5.3 OTHERS
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 APPROVALS
10.3 NEW PRODUCT LAUNCH
10.4 EXPANSION
10.5 AGREEMENTS, PARTNERSHIPS AND COLLABORATION
10.6 OTHERS
11 MAJOR COMPANIES
11.1 ASAHI KASEI CORPORATION (ZOLL MEDICAL)
ÌýÌý11.1.1 OVERVIEW
ÌýÌý11.1.2 FINANCIALS
ÌýÌý11.1.3 PRODUCT PORTFOLIO
ÌýÌý11.1.4 KEY DEVELOPMENTS
ÌýÌý11.1.5 BUSINESS STRATEGY
ÌýÌý11.1.6 SWOT ANALYSIS
11.2 AIR LIQUIDE S.A.
ÌýÌý11.2.1 OVERVIEW
ÌýÌý11.2.2 FINANCIALS
ÌýÌý11.2.3 PRODUCT PORTFOLIO
ÌýÌý11.2.4 KEY DEVELOPMENTS
ÌýÌý11.2.5 BUSINESS STRATEGY
ÌýÌý11.2.6 SWOT ANALYSIS
11.3 DRAEGERWERK AG & CO. KGAA
ÌýÌý11.3.1 OVERVIEW
ÌýÌý11.3.2 FINANCIALS
ÌýÌý11.3.3 PRODUCT PORTFOLIO
ÌýÌý11.3.4 KEY DEVELOPMENTS
ÌýÌý11.3.5 BUSINESS STRATEGY
ÌýÌý11.3.6 SWOT ANALYSIS
11.4 GENERAL ELECTRIC COMPANY (GE HEALTHCARE)
ÌýÌý11.4.1 OVERVIEW
ÌýÌý11.4.2 FINANCIALS
ÌýÌý11.4.3 PRODUCT PORTFOLIO
ÌýÌý11.4.4 KEY DEVELOPMENTS
ÌýÌý11.4.5 BUSINESS STRATEGY
ÌýÌý11.4.6 SWOT ANALYSIS
11.5 GETINGE GROUPS (MAQUET GMBH & CO. KG)
ÌýÌý11.5.1 OVERVIEW
ÌýÌý11.5.2 FINANCIALS
ÌýÌý11.5.3 PRODUCT PORTFOLIO
ÌýÌý11.5.4 KEY DEVELOPMENTS
ÌýÌý11.5.5 BUSINESS STRATEGY
ÌýÌý11.5.6 SWOT ANALYSIS
11.6 KONINKLIJKE PHILIPS N.V.
ÌýÌý11.6.1 OVERVIEW
ÌýÌý11.6.2 FINANCIALS
ÌýÌý11.6.3 PRODUCT PORTFOLIO
ÌýÌý11.6.4 KEY DEVELOPMENTS
ÌýÌý11.6.5 BUSINESS STRATEGY
ÌýÌý11.6.6 SWOT ANALYSIS
11.7 RESMED INC.
ÌýÌý11.7.1 OVERVIEW
ÌýÌý11.7.2 FINANCIALS
ÌýÌý11.7.3 PRODUCT PORTFOLIO
ÌýÌý11.7.4 KEY DEVELOPMENTS
ÌýÌý11.7.5 BUSINESS STRATEGY
ÌýÌý11.7.6 SWOT ANALYSIS
11.8 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONIC CO., LTD.
ÌýÌý11.8.1 OVERVIEW
ÌýÌý11.8.2 FINANCIALS
ÌýÌý11.8.3 PRODUCT PORTFOLIO
ÌýÌý11.8.4 KEY DEVELOPMENTS
ÌýÌý11.8.5 BUSINESS STRATEGY
ÌýÌý11.8.6 SWOT ANALYSIS
11.9 VYAIRE MEDICAL, INC
ÌýÌý11.9.1 OVERVIEW
ÌýÌý11.9.2 FINANCIALS
ÌýÌý11.9.3 PRODUCT PORTFOLIO
ÌýÌý11.9.4 KEY DEVELOPMENTS
ÌýÌý11.9.5 BUSINESS STRATEGY
ÌýÌý11.9.6 SWOT ANALYSIS
11.10 VENTEC LIFE SYSTEMS
ÌýÌý11.10.1 OVERVIEW
ÌýÌý11.10.2 FINANCIALS
ÌýÌý11.10.3 PRODUCT PORTFOLIO
ÌýÌý11.10.4 KEY DEVELOPMENTS
ÌýÌý11.10.5 BUSINESS STRATEGY
ÌýÌý11.10.6 SWOT ANALYSIS
Ìý
Ìý
*If Applicable.